Effects of chronic glucagon administration on rat lipoprotein composition
- PMID: 2804052
- DOI: 10.1016/0005-2760(89)90042-8
Effects of chronic glucagon administration on rat lipoprotein composition
Abstract
Male adult rats of the Wistar strain received daily at 9 a.m. and 5 p.m. 10 micrograms of Zn-protamine glucagon (Novo) for 21 days by subcutaneous injections. Plasma levels of cholesterol, triacylglycerol and phospholipids were decreased by 47, 40 and 21%, respectively. Lipoproteins were separated by sequential ultracentrifugation. Concentrations of cholesterol, phospholipids and proteins were decreased in chylomicrons, VLDL, LDL2 (1.040-1.063 g/ml) and HDL, LDL2 being the most affected by glucagon treatment (-70%). Triacylglycerol levels were decreased only in chylomicrons and VLDL. The relative proportions of cholesterol, triacylglycerol, phospholipids and proteins in lipoproteins were virtually unchanged by glucagon, suggesting a reduced number of some lipoprotein particles in plasma. However, lipoproteins of glucagon-treated rats were depleted in cholesteryl esters, while the proportion of triacylglycerol increased in LDL and HDL. Apo E contents were decreased in plasma, LDL1 (1.006-1.040 g/ml), LDL2 and HDL, whereas apo B100 proportions increased in VLDL and LDL1 in glucagon-treated rats. Glucagon appeared to be a potent hypolipidemic agent affecting mainly the apo-E-rich lipoproteins.
Similar articles
-
Effect of portacaval anastomosis on rat lipoproteins.Clin Physiol Biochem. 1986;4(2):164-72. Clin Physiol Biochem. 1986. PMID: 3698474
-
Comparative analysis of mammalian plasma lipoproteins.Methods Enzymol. 1986;128:70-143. doi: 10.1016/0076-6879(86)28063-5. Methods Enzymol. 1986. PMID: 3523143 Review. No abstract available.
-
Effect of chronic glucagon administration on the metabolism of triacylglycerol-rich lipoproteins in rats fed a high sucrose diet.J Nutr. 1991 Jan;121(1):24-30. doi: 10.1093/jn/121.1.24. J Nutr. 1991. PMID: 1992054
-
Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats.Lipids. 1991 Jun;26(6):451-8. doi: 10.1007/BF02536072. Lipids. 1991. PMID: 1881241
-
[Some aspects of lipoprotein metabolism].Biochimie. 1976;58(8):971-80. doi: 10.1016/s0300-9084(76)80285-4. Biochimie. 1976. PMID: 186132 Review. French. No abstract available.
Cited by
-
Glucagon kinetics assessed by mathematical modelling during oral glucose administration in people spanning from normal glucose tolerance to type 2 diabetes.Front Endocrinol (Lausanne). 2024 Apr 12;15:1376530. doi: 10.3389/fendo.2024.1376530. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38681771 Free PMC article.
-
Glucagon receptor signaling at white adipose tissue does not regulate lipolysis.Am J Physiol Endocrinol Metab. 2022 Oct 1;323(4):E389-E401. doi: 10.1152/ajpendo.00078.2022. Epub 2022 Aug 24. Am J Physiol Endocrinol Metab. 2022. PMID: 36002172 Free PMC article.
-
Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients.Nutrients. 2022 Jan 16;14(2):376. doi: 10.3390/nu14020376. Nutrients. 2022. PMID: 35057557 Free PMC article. Clinical Trial.
-
Integrating the inputs that shape pancreatic islet hormone release.Nat Metab. 2019 Dec;1(12):1189-1201. doi: 10.1038/s42255-019-0148-2. Epub 2019 Dec 13. Nat Metab. 2019. PMID: 32694675 Free PMC article. Review.
-
Role of Glucagon in Automated Insulin Delivery.Endocrinol Metab Clin North Am. 2020 Mar;49(1):179-202. doi: 10.1016/j.ecl.2019.10.008. Epub 2019 Dec 10. Endocrinol Metab Clin North Am. 2020. PMID: 31980117 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
